|Age:||3 to 17 years old|
|Keywords:||Fragile X Syndrome|
|Type:||Drug study, Phase [2, 3]|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.